Selective activation of pro-inflammatory cytokines in obstructive sleep apnoea syndrome and impact of CPAP Source: Eur Respir J 2005; 26: Suppl. 49, 355s Year: 2005
The role of pro- and anti- inflammatory cytokines in the pathogenesis of obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Production of TNF-α, MMPs, and MCP-1 by monocytes and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004
Proinflammatory cytokines in patients with congestive heart failure and sleep disordered breathing Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008
The influence of smoking on the level of proinflammatory cytokines in patients with COPD Source: Annual Congress 2012 - Tobacco dependence and respiratory disease Year: 2012
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006
Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2006 - Metabolic control in obstructive sleep apnoea Year: 2006
Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
The effect of chronic intermittent hypoxia on bone homeostasis in children with sleep disordered breathing Source: Annual Congress 2012 - Sleep monitoring, lung function and inflammation in childhood Year: 2012
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Differential regulation of cytokine production is mediated by IL-17 in obese children with obstructive sleep apnoea Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016
Impact of bi-Level ventilation on sleep disordered breathing in patients using chronic opioids Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure Year: 2010
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8 Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
The severity of sleep-disordered breathing is independently associated with increased peripheral leukocytes and neutrophils in overweight children and adolescents Source: Annual Congress 2007 - Sleep apnoea in childhood Year: 2007
Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004
Effect of continuous positive airway pressure (CPAP) treatment on proangiogenic factors of angiogenesis in obstructive sleep apnea (OSA) patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005
The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Long term effect of APAP on C-reactive protein and IL-6 in obstructive sleep apnoea patients Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008
CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea Source: Eur Respir J 2008; 32: 1009-1015 Year: 2008
Endothelin-1 levels, respiratory drive and hypercapnic response in obese patients with or without obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010